Clinical Trial

Effect of In-Place Slow Jogging on Metabolic Dysfunction-Associated Steatotic Liver Disease

Name: Effect of In-Place Slow Jogging on Metabolic Dysfunction-Associated Steatotic Liver Disease — clinical trial record (NCT06994234)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Evaluating the Effectiveness, Safety, and Feasibility of Stationary Ultra-Slow Running in Treating MASLD Patients.

Trial Details

NCT Number	NCT06994234
Lead Sponsor	Shanghai East Hospital
Conditions	Metabolic Dysfunction-Associated Steatotic Liver Disease
Enrollment	82 participants
Start Date	2025-06-20
Primary Completion	2027-06-20 (estimated)
Study Completion	2028-06-20 (estimated)
Updated on ClinicalTrials.gov	2025-05-29